Pfizer and Novo Nordisk's fight for obesity drug developer Metsera ratcheted up on Tuesday, as both companies submitted ...
Eli Lilly and Novo Nordisk plan to announce new drug pricing deals with the White House, including for their weight loss ...
Eli Lilly and Novo Nordisk plan to announce new drug pricing deals with the White House, including for their weight loss ...
Shares in Metsera shot up nearly 20% to more than $72 after news of the renewed bidding war emerged, raising its market ...
Investor's Business Daily on MSN
Novo Sweetens Its Bid For Metsera As Takeover Drama With Pfizer Escalates
Novo Nordisk said it would pay up to $10 billion to acquire obesity-focused Metsera, topping Pfizer's recently hiked $8.1 ...
Investing.com -- Eli Lilly and Novo Nordisk are planning to announce new drug pricing deals with the White House that include their weight loss medicines, according to a Tuesday report from Endpoints ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback